LH: Labcorp Reaffirms 2026-2029 Long-Term Outlook with 5-8% Revenue, 8.5-11.5% EPS Growth
· The NYC Memo
Labcorp Holdings Inc. reaffirmed its long-term financial outlook for 2026-2029 on September 22, 2026, following preliminary CMS payment rates. The outlook includes compound annual revenue growth between 5% and 8%, adjusted operating margin expansion of 75 to 150 basis points by the end of 2029, and compound annual adjusted EPS growth between 8.5% and 11.5%.
Labcorp stated it continues to support the RESULTS Act while evaluating the full impact of the CMS rates on its 2027 financial guidance, expected in February 2027.